Back
Cellectar Biosciences Vs. Zymeworks Industry Stock Comparison
Sell
23
CLRB
Cellectar Biosciences
Last Price:
0.24
Seasonality Move:
-1.67%
Buy
60
ZYME
Zymeworks
Last Price:
12.59
Seasonality Move:
-3.97%
Sell
23
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $0.26. The Score for CLRB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zymeworks (ZYME)
is a Buy
Is Zymeworks a Buy, Sell or Hold?
- The current Zymeworks [ZYME] share price is $12.62. The Score for ZYME is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ZYME is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $0.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
CLRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 5.91 | Sell |
| Chaikin Money Flow: | -6267615 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.11 - 2.03) | Sell |
| Bollinger Bands (100): | (1.63 - 2.29) | Sell |
ZYME Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 34.34 | Sell |
| Chaikin Money Flow: | -409164 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.4 - 16.14) | Sell |
| Bollinger Bands (100): | (10.91 - 14.47) | Sell |
CLRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Sell |
| 20-day SMA: | 1.43 | Sell |
| 50-day SMA: | 1.82 | Sell |
| 200-day SMA: | 2.6 | Sell |
| 8-day EMA: | 0.97 | Sell |
| 20-day EMA: | 1.34 | Sell |
| 50-day EMA: | 1.69 | Sell |
| 200-day EMA: | 2.29 | Sell |
ZYME Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.55 | Sell |
| 20-day SMA: | 14.19 | Sell |
| 50-day SMA: | 14.05 | Sell |
| 200-day SMA: | 11.09 | Buy |
| 8-day EMA: | 13.42 | Sell |
| 20-day EMA: | 13.98 | Sell |
| 50-day EMA: | 13.81 | Sell |
| 200-day EMA: | 11.69 | Buy |
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.81 per share.
Zymeworks Earnings Growth & ZYME Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and a decrease next year of $0.11 per share.
Cellectar Biosciences Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zymeworks Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||